Rare diseases
Investigational molecules
Locations
Antikalamos, 241 00 Kalamata, Greece
General Hospital Of Messinia in Kalamata, Greece specialises in clinical trials of conditions such as Cardiac failure, Endometrial cancer recurrent, Obesity, Fallopian tube cancer, and other specialisations. This site conducts important research.
The medical center is at the forefront of oncology research, focusing on innovative treatments for endometrial cancer. The center's work is pivotal in advancing therapeutic options for patients who have undergone platinum-based chemotherapy and immunotherapy.
Through rigorous clinical trials, the center is exploring the efficacy of novel agents like sacituzumab govitecan, offering hope for improved patient outcomes.
Clinical trials currently enrolling participants at this site.
Study of Zenagamtide (NNC0487-0111) versus placebo in patients with heart failure with preserved or mildly reduced ejection fraction and obesity
GreecePhase 3 Study of LY4170156 (Sofetabart Mipitecan) with drug combination in platinum‑resistant and platinum‑sensitive ovarian cancer patients
GreeceComparing AZD5335 with Mirvetuximab Soravtansine or a drug combination in patients with platinum-resistant ovarian cancer
GreeceA study comparing BNT323 with chemotherapy in patients with HER2-expressing recurrent endometrial cancer who received previous treatment
GreeceA study comparing ziltivekimab to placebo in patients with heart failure with mildly reduced or preserved ejection fraction and inflammation
GreeceStudy on the Effectiveness of Weekly IcoSema (Insulin Icodec and Semaglutide) vs. Daily Insulin Glargine for Adults with Type 2 Diabetes Not Controlled by Oral Drugs
GreeceA Phase 3 Randomized Open-Label Study of Sacituzumab Govitecan Versus Physician's Choice in Recurrent or Persistent Endometrial Cancer Post-Chemotherapy and Immunotherapy
GreeceGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
